04/16/2026 02:00
Toshiba Starts Sample Shipments of New “SmartMCD™” Series Product Integrating Microcontroller and Motor Driver

Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started to ship engineering samples of “TB9M030FG,” the latest addition to its “SmartMCD™”[1] series of motor control devices. The new device integrates a microcontroller (MCU) and a motor driver, and incorporates sensorless control technology for low‑speed operation of three‑phase brushless DC motors. TB9M030FG is suitable for sensorless control of the three‑phase brushless DC motors used in automotive applications, such as e...

04/16/2026 05:01
Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building

Ferring Pharmaceuticals and Gallup today announced the Ferring Global Fertility Monitor, a global study on the factors influencing people’s fertility choices, at the 2026 Annual Convening of Semafor World Economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415305082/en/ The Ferring Global Fertility Monitor is grounded in the recognition that declining global fertility rates are an increasingly significant public policy topic,...

04/16/2026 05:00
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Regenerating Skin Nectar with TriHex+™, the newest innovation from Alastin, a leader in peptide-based regenerative skincare. As a pioneer in peri‑procedural skincare, Alastin helped establish the category with the original Regenerating Skin Nectar — one of the first products specifically developed to prepare the skin before cosmetic procedures, complement procedural outcomes, and visibly support a s...

04/16/2026 06:00
Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the Group’s New CEO

At the Board of Directors meeting held on April 15, 2026, Juvisé Pharmaceuticals officially acknowledged the resignation of Frédéric Mascha from his role as CEO of the pharmaceutical group and his appointment as Executive Chairman and Chairman of the Supervisory Committee. The Board of Directors appointed Renaud Sermondade as the Group’s new CEO, effective July 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415884303/en/...

04/16/2026 06:00
HW International Rebrands as Dubois, Uniting Its Business Under One Global Name

HW International has rebranded to Dubois, bringing its European and Australian operations together under a single global identity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415999888/en/Maurits Kleingeld, Owner, Dubois In Australia, this includes a company name change from HW Wood Australia Pty Ltd to Dubois Insurance Pty Ltd, completing the group’s transition to a single unified identity across all markets. The move follo...